Biosyent's market cap is currently C$127.29M. The company's EPS TTM is C$0.61; its P/E ratio is 18.16; and it has a dividend yield of 1.62%. Biosyent is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is C$0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 31.59M	C$ 27.93M	C$ 28.62M	C$ 22.33M	C$ 21.42M
Gross Profit	C$ 25.60M	C$ 22.86M	C$ 22.64M	C$ 17.42M	C$ 16.65M
Operating Income	C$ 7.47M	C$ 6.98M	C$ 8.18M	C$ 5.03M	C$ 5.39M
EBITDA	C$ 9.06M	C$ 7.96M	C$ 8.92M	C$ 5.84M	C$ 6.19M
Net Income	C$ 6.46M	C$ 5.46M	C$ 6.28M	C$ 3.80M	C$ 4.37M
Balance Sheet
Cash & Short-Term Investments	C$ 26.19M	C$ 28.70M	C$ 28.21M	C$ 25.58M	C$ 21.97M
Total Assets	C$ 41.53M	C$ 40.49M	C$ 37.17M	C$ 33.57M	C$ 30.97M
Total Debt	C$ 1.22M	C$ 1.40M	C$ 1.56M	C$ 1.71M	C$ 1.85M
Net Debt	C$ -6.76M	C$ -6.47M	C$ -16.48M	C$ -18.58M	C$ -11.59M
Total Liabilities	C$ 6.77M	C$ 7.12M	C$ 5.61M	C$ 6.78M	C$ 5.17M
Stockholders' Equity	C$ 34.76M	C$ 33.36M	C$ 31.55M	C$ 26.80M	C$ 25.79M
Cash Flow
Free Cash Flow	C$ 4.88M	C$ 4.43M	C$ 4.58M	C$ 6.72M	C$ 4.04M
Operating Cash Flow	C$ 5.05M	C$ 4.95M	C$ 4.67M	C$ 6.89M	C$ 4.77M
Investing Cash Flow	C$ 883.85K	C$ -10.79M	C$ -4.84M	C$ 3.39M	C$ -1.68M
Financing Cash Flow	C$ -5.78M	C$ -4.37M	C$ -2.08M	C$ -3.37M	C$ -6.39M

Currency in CAD

Biosyent Earnings and Revenue History

Income Statement >

Biosyent Debt to Assets

Balance Sheet >

Biosyent Cash Flow

Cash Flow >

Biosyent Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing